![]() |
市場調查報告書
商品編碼
1754291
2025 年至 2033 年一次性注射器市場規模、佔有率、趨勢及預測(按產品類型、應用、最終用戶和地區)Disposable Syringes Market Size, Share, Trends and Forecast by Product Type, Application, End User, and Region, 2025-2033 |
2024年,全球一次性注射器市場規模為161.1億美元。展望未來, IMARC Group估計,到2033年,市場規模將達到288.9億美元,2025-2033年期間的複合年成長率為6.37%。北美目前佔據市場主導地位,2024年將佔據超過41.6%的市場。北美一次性注射器市場佔有率的成長受到疫苗需求成長、慢性病盛行率上升以及醫療保健投資增加等因素的驅動。此外,對感染控制、安全法規的認知提高以及無針注射系統的採用也促進了該地區市場的成長和創新。
糖尿病、癌症和心血管疾病等慢性病的發生率不斷上升,使得注射藥物和胰島素的需求量不斷增加,一次性注射器也應運而生。此外,國際社會對清潔和避免感染的日益關注,促使人們轉向使用一次性注射器,以最大程度地減少交叉污染和針刺傷害。各國政府和醫療機構也正在製定更嚴格的安全準則,鼓勵使用一次性注射器,以保障醫護人員和病患的安全。此外,疫苗需求的增加,尤其是由於新冠疫情,加速了用於大規模免疫接種的一次性注射器的需求。包括自毀式注射器和預充式注射器在內的技術進步,正在提高患者的安全性和可用性,促進創新以及一次性注射器市場的成長。
美國是市場顛覆的關鍵力量,其驅動力源自於先進的醫療基礎設施、創新和監管標準等因素。美國高度重視醫療保健,加上糖尿病、心血管疾病和癌症等慢性病的高發生率,刺激了對注射藥物的需求,從而促進了一次性注射器的使用。在美國,疫苗接種也是國家活動的中心,尤其是在新冠疫情期間,這進一步刺激了對一次性注射器的需求,以促進大規模疫苗接種。此外,美國在醫療器材創新方面處於領先地位,例如在預充式注射器、自毀式注射器和無針注射器的設計方面。美國食品藥物管理局 (FDA) 等更嚴格的監管環境要求注射器產業提高安全性和創新水準。此外,美國遠距醫療和家庭醫療保健服務的大規模使用也增加了對一次性注射器的需求,進一步加劇了市場顛覆。
安全注射器的需求不斷增加
一次性注射器市場對安全設計的注射器的需求日益成長,這源於減少針刺傷和傳染病傳播的需求。這些注射器配備了安全裝置,可在使用後自動縮回或覆蓋針頭,從而增強了對醫護人員和患者的保護。醫院和診所擴大採用此類注射器,尤其是在急診等高風險環境中。隨著安全規程意識的不斷提高,加上醫療法規的日益嚴格,安全設計的一次性注射器市場不斷擴張,這不僅促進了產業發展,也有助於提高整體醫療安全標準。最近,印度斯坦注射器和醫療器材公司 (HMD) 推出了配備安全針頭的 Dispojekt 一次性注射器,進一步鞏固了印度作為全球醫療器材領導者的地位。
注射器設計的技術進步
注射器設計的創新是一次性注射器市場的關鍵趨勢。製造商正在融入新技術,以提升注射器的性能、易用性和患者的舒適度。預充式注射器的開發是其中一項重大進展,它在疫苗、生物製劑和注射藥物的注射中越來越受歡迎。預充式注射器降低了劑量錯誤的風險,提高了藥物傳遞的效率,並確保了劑量的一致性和準確性。這些注射器也迎合了日益成長的居家自我給藥趨勢,尤其是在糖尿病等慢性疾病中,這推動了對先進一次性注射器解決方案的需求。最近,德國藥物容器和輸送解決方案供應商肖特製藥 (SCHOTT Pharma) 推出了新一代肖特 TOPPAC 聚合物注射器,該系統旨在提高安全性和效率。同時,印度孟買理工學院 (IIT Bombay) 的研究人員發明了一種無針注射器,它利用衝擊波,確保安全無痛的給藥,同時最大限度地減少皮膚損傷並降低感染風險。這些發展進一步推動了一次性注射器市場的發展。
疫苗接種使用率不斷成長
近年來,由於疫苗需求成長,尤其是在新冠疫情之後,一次性注射器市場經歷了顯著成長。一次性注射器因其無菌、安全、便捷的特點,被廣泛用於疫苗接種。各國政府和醫療機構正在加強疫苗接種力度,這帶來了巨大的注射器需求,尤其是在大規模免疫接種工作中。隨著全球疫苗接種計畫的持續推進,一次性注射器對於實現公共衛生目標至關重要。預計這一趨勢將持續下去,隨著對注射器生產的持續投資,確保穩定的供應,以滿足全球日益成長的疫苗接種需求。
The global disposable syringes market size was valued at USD 16.11 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 28.89 Billion by 2033, exhibiting a CAGR of 6.37% during 2025-2033. North America currently dominates the market, holding a significant market share of over 41.6% in 2024. The North American disposable syringes market share is driven by factors such as the growing demand for vaccines, increasing chronic disease prevalence, and rising healthcare investments. Additionally, heightened awareness about infection control, safety regulations, and the adoption of needleless injection systems contribute to the market's growth and innovation in the region.
The growing incidence of chronic diseases like diabetes, cancer, and cardiovascular diseases has made injectable medications and insulin in greater demand, necessitating disposable syringes. Additionally, the growing international concern regarding cleanliness and infection avoidance has resulted in a shift toward single-use syringes for minimizing cross-contamination and needle-stick injury. Governments and healthcare institutions are also adopting stricter safety guidelines, encouraging the use of disposable syringes to safeguard both healthcare professionals and patients. Furthermore, increased demand for vaccines, especially due to the COVID-19 pandemic, has speeded up the demand for disposable syringes for mass immunizations. Technological advancements, including the creation of auto-disable syringes and pre-filled syringes, are improving patient safety and usability, encouraging innovation along with disposable syringes market growth.
The United States stands out as a key market disruptor, driven by factors such as advanced healthcare infrastructure, innovation, and regulatory standards. The nation's robust emphasis on healthcare coupled with its high prevalence of chronic conditions such as diabetes, cardiovascular diseases, and cancer has fueled high demand for injectable drugs, hence inducing use of disposable syringes. Vaccine delivery in the US is also at the center of the country's activity, especially during the COVID-19 pandemic, further boosting demand for disposable syringes to facilitate mass vaccination. Further, the US is in the vanguard of medical device innovation, such as in the design of pre-filled syringes, auto-disable syringes, and needle-free injectors. More stringent regulatory environments, such as in the form of the FDA, have required increased levels of safety and innovation within the syringe industry. In addition, the mass use of telemedicine and home healthcare services in the US has also increased the need for disposable syringes, further increasing market disruption.
Increasing demand for safety-engineered syringes
The disposable syringes market is witnessing a growing demand for safety-engineered syringes, driven by the need to minimize needle-stick injuries and reduce the transmission of infectious diseases. These syringes are equipped with safety mechanisms that automatically retract or cover the needle after use, enhancing protection for both healthcare workers and patients. Hospitals and clinics are increasingly adopting these syringes, particularly in high-risk environments like emergency care settings. The rising awareness about safety protocols, combined with stricter healthcare regulations, has led to an expansion in the market for safety-engineered disposable syringes, supporting industry growth and contributing to the improvement of overall healthcare safety standards. Recently, Hindustan Syringes and Medical Devices (HMD) introduced Dispojekt single-use syringes equipped with safety needles, enhancing India's role as a global leader in medical devices.
Technological advancements in syringe design
Innovation in syringe design is a key trend in the disposable syringes market. Manufacturers are incorporating new technologies to enhance syringe performance, ease of use, and patient comfort. One significant advancement is the development of prefilled syringes, which are increasingly preferred for vaccines, biologics, and injectable drugs. Prefilled syringes reduce the risk of dosing errors, improve the efficiency of drug delivery, and ensure a consistent and accurate dose. These syringes also cater to the growing trend of at-home self-administration of medications, especially for chronic conditions such as diabetes, boosting the demand for advanced disposable syringe solutions. Recently, SCHOTT Pharma, a German supplier of drug containment and delivery solutions, introduced the next generation of SCHOTT TOPPAC infuse polymer syringes, a system aimed at enhancing safety and efficiency. In the meantime, researchers at IIT Bombay in India have created a needle-free syringe that uses shockwaves, ensuring safe and painless drug administration while minimizing skin damage and reducing the risk of infection. These developments further continue to fuel the market for disposable syringes.
Growing usage in vaccine administration
The disposable syringes market has experienced significant growth in recent years due to the increased demand for vaccines, especially following the COVID-19 pandemic. Disposable syringes are widely used for vaccine delivery due to their sterility, safety, and convenience. Governments and healthcare organizations are ramping up vaccination campaigns, creating a substantial need for syringes, particularly in large-scale immunization efforts. With the continued global push for vaccination programs, disposable syringes are integral to meeting public health goals. This trend is expected to persist, with continuous investments in syringe production, ensuring a steady supply to meet the growing needs of vaccination drives worldwide.
Safety syringes stand as the largest component in 2024, holding around 80.9% of the market. Safety syringes represent a major segment of the disposable syringes market, fueled by the growing need for improved safety features in healthcare environments. Safety syringes are intended to minimize the risk of needle-stick injuries, which can result in the transmission of infectious diseases like HIV, hepatitis, and other bloodborne pathogens. Safety syringes usually have an intrinsic safety mechanism that protects the needle after being used, providing safety to healthcare workers during and after injections. With increasing need for healthcare worker safety and patient health, usage of safety syringes has increased, especially in hospitals, clinics, and other healthcare facilities. Regulatory agencies like the FDA and OSHA have also tightened safety standards, further prompting the use of safety syringes. Increased needle-stick injuries, as well as growing rates of chronic diseases that necessitate repeated injections, have boosted this segment, making safety syringes an integral component of the disposable syringes market.
Therapeutic injections lead the market with around 75.1% of market share in 2024. Therapeutic injections account for a major portion of the application segment within the disposable syringes market, fueled by the growing demand for injectable drugs in numerous therapeutic categories. Therapeutic injections are frequently employed for the management of chronic diseases like diabetes, arthritis, cancer, and cardiovascular diseases, which tend to need long-term medication administration. Diabetes management through insulin injections is a key driver in this segment, with the global incidence of diabetes still on the increase. Biologic therapies, such as monoclonal antibodies and other high-value drugs, also depend significantly on injectable formulations, further increasing demand for disposable syringes. The convenience, ease of use, and precision offered by disposable syringes in delivering therapeutic injections make them a critical instrument in healthcare facilities. In addition, the increasing popularity of home-based healthcare and self-injectors, along with emerging trends in pre-filled syringes, has favored the growth of therapeutic injections as a vital application segment in the disposable syringes market outlook.
Hospitals leads the market with around 43.7% of market share in 2024. Hospitals form a major segment of the end-user market in disposable syringes due to the demand for safe, efficient, and sterile injection techniques in healthcare. The large patient volume and varied treatment needs in hospitals make them core users of disposable syringes for a range of medical procedures, such as injections, blood withdrawal, and administration of anesthesia. The frequency of high doses of medications given in hospitals, especially for long-term illnesses like diabetes, cancer, and infectious diseases, makes the extensive use of disposable syringes inevitable. Furthermore, hospitals ensure safety to avoid needle-stick injuries and the spread of infection, and this results in the increased use of safety syringes and auto-disable syringes. As hospitals are confronting increasing patient volumes and growing emphasis on infection prevention and patient safety, demand for disposable syringes is projected to keep growing. In addition, the trend toward the use of advanced healthcare technologies, including pre-filled syringes and injectable biologics, continues to grow the demand for disposable syringes in the hospital environment.
In 2024, North America accounted for the largest market share of over 41.6%. North America is the leading region for the disposable syringes market, with support from developed healthcare infrastructure, immense healthcare expenditure, and a large incidence of chronic diseases. The United States holds the position of the largest market in this region, with significant demand for disposable syringes supported by widespread injectable medication use for conditions like diabetes, cardiovascular diseases, and cancer. Moreover, the region's well-established healthcare system of hospitals, clinics, and outpatient facilities requires constant use of disposable syringes for procedures such as vaccinations, blood extraction, and therapeutic injections. Increasing emphasis on safety and prevention of needle-stick injury has further promoted the usage of safety syringes in North America. Regulatory authorities such as the FDA also take a key role in maintaining stringent standards of quality and safety in syringes. In addition, the developing trend towards home healthcare and home injection treatments is fueling the demand for North American disposable syringes.
United States Disposable Syringes Market Analysis
In 2024, the United States accounted for over 93.30% of the disposable syringes market in North America. The growth of the disposable syringes market in the United States is significantly influenced by the high prevalence of chronic diseases. An estimated 129 Million people in the U.S. suffer from at least one major chronic condition, such as heart disease, cancer, diabetes, obesity, or hypertension, as defined by the U.S. Department of Health and Human Services. This growing burden of chronic diseases fuels the demand for injectable treatments, driving the need for disposable syringes. Alongside this, advancements in healthcare infrastructure and a shift toward injectable biologics further contribute to market expansion. The increasing focus on hygiene and safety, along with measures to prevent needle-stick injuries, strengthens demand. Government initiatives, such as needle exchange programs and the push for eco-friendly products, further bolster growth. The COVID-19 pandemic also accelerated syringe demand due to mass vaccination efforts. With a rise in home healthcare, where patients self-administer injections, disposable syringes offer convenience and safety, pushing the market forward. Innovations in syringe design, such as safety-engineered and self-destructive syringes, enhance user safety and support continued market growth. Increased outpatient treatments and surgeries also contribute to the higher demand for disposable syringes.
Asia Pacific Disposable Syringes Market Analysis
The disposable syringes market in the Asia-Pacific (APAC) region is propelled by rapid urbanization, rising healthcare spending, and an aging population. According to reports, the number of older persons in Asia and the Pacific is projected to more than double, from 630 Million in 2020 to approximately 1.3 Billion by 2050, further increasing the demand for injectable treatments. Additionally, the cancer incidence in Asia, as reported, was 169.1 per 100,000 in 2020, accounting for 49.3% of global cancer cases, with lung, breast, and colorectal cancers being the most prevalent. These factors drive the need for syringes, as injectable therapies are increasingly utilized in cancer treatment and other chronic conditions. The growing preference for self-administered medications also boosts market demand, with disposable syringes offering convenience and safety. Expanding healthcare infrastructure in developing nations, such as India and China, and government initiatives to improve healthcare standards further support the market's growth in the region.
Europe Disposable Syringes Market Analysis
The disposable syringes market in Europe is primarily driven by the growing incidence of chronic diseases, especially diabetes, and an aging population. According to reports, as of January 1, 2023, the EU population was estimated at 448.8 Million, with more than one-fifth (21.3%) aged 65 years and over. This demographic shift increases the demand for injectable treatments, as the elderly are more prone to chronic conditions that require ongoing medical intervention. The rise in injectable biologics and biosimilars further boosts the market for disposable syringes, which are favored for their safety, affordability, and ease of use. Stringent regulatory frameworks in the region ensure the availability of high-quality products, bolstering consumer trust. Technological innovations, such as retractable and safety-engineered syringes, enhance user safety and contribute to market growth. The increasing number of surgeries, outpatient care services, and vaccination campaigns, particularly during health crises like the COVID-19 pandemic, further support demand. Additionally, Europe's growing focus on sustainable and eco-friendly medical products aligns with the demand for environmentally conscious disposable syringes. The increasing trend toward home healthcare services, where disposable syringes are widely used for self-administration, is also expected to drive market expansion in the region.
Latin America Disposable Syringes Market Analysis
The disposable syringes market in Latin America is driven by the rising prevalence of chronic diseases, which are expected to cause 928,000 deaths annually in Brazil alone, underscoring the growing demand for injectable treatments, including stem cell therapies. The expansion of healthcare access and increasing healthcare expenditure, particularly in countries like Brazil and Mexico, further fuels market growth. Government initiatives to improve healthcare infrastructure and promote awareness are key growth factors. The adoption of injectable therapies and biologics continues to support the increasing demand for disposable syringes across the region.
Middle East and Africa Disposable Syringes Market Analysis
In the Middle East and Africa, the disposable syringes market is influenced by the prevalence of chronic diseases, with 23% of the population in the UAE reporting such conditions. Obesity (12.5%), diabetes (4.2%), and asthma/allergies (3.2%) are among the most common. This growing burden of chronic diseases contributes to the increased need for injectable treatments. Along with healthcare infrastructure improvements, the rising demand for vaccinations and self-administered medications further supports the market. Technological advancements in syringe design and government efforts to improve healthcare access are key drivers of market expansion in the region.
Several leading companies in the disposable syringes market are aggressively pursuing growth through various strategic initiatives on innovation, safety, and geographic expansion. Top players are heavily investing in research and development to design sophisticated products like safety syringes, pre-filled syringes, and auto-disable syringes that go a long way in ensuring safety and ease of injection procedures. These syringes have safety mechanisms against needle-stick injuries, which tackle key healthcare issues in infection control. To address increasing demand for injectable drugs, especially for long-term conditions such as diabetes, industry stakeholders are also concentrating on creating affordable, high-quality solutions that suit healthcare professionals and patients alike. Further, collaborations with pharmaceutical firms to manufacture specialized syringes for particular drugs, including biologics and vaccines, are also on the rise. Scaling up production capacities and enhancing distribution networks to make disposable syringes widely available, particularly in the emerging markets, is another priority area. Additionally, strategic partnerships with healthcare institutions and adherence to strict regulatory standards, including those of the FDA and WHO, guarantee product safety and quality.